Events

Intratumor microbiota: a novel tumor component

Intratumor microbiota: a novel tumor component

Bacteria have been found in tumors for over 100 years, but the irreproducibility of experiments on bacteria, the limitations of science and technology, and the contamination of the host environment have severely hampered most research into the role of bacteria in...

Advances in the Microbiome, Immunity and Cancer interplay

Advances in the Microbiome, Immunity and Cancer interplay

Gut microbiome plays an important role in colorectal cancer (CRC) initiation, progression and response to different systemic therapies. On its turn, gut microbiome is influenced by host factors (race, sex, genetic predisposition, oxidative stress, metabolic and...

Microbiome therapies: a maturing movement

Microbiome therapies: a maturing movement

On World Microbiome Day 2023, Hervé Affagard, CEO and co-founder of MaaT Pharma and Jeffrey Silber, Chief Medical Officer of Vedanta Biosciences delve into the current innovative landscape of microbiome-based therapeutics. Riding on the momentum of the first faecal...

Live Biotherapeutic Products as Cancer Treatments

Live Biotherapeutic Products as Cancer Treatments

Almost every aspect of cancer can be influenced by microbiota including tumor onset, progression, and response to therapy. The increasing evidence of the role of microbiota in human health and disease has reinvigorated the interest in designing microbial products that...